Literature DB >> 1523879

Production of porcine parvovirus empty capsids with high immunogenic activity.

C Martínez1, K Dalsgaard, J A López de Turiso, E Cortés, C Vela, J I Casal.   

Abstract

The VP2 gene of porcine parvovirus was cloned in the baculovirus system and expressed in insect cells. The resulting product was present in high yield. It self-assembled into particles which were structurally and antigenically indistinguishable from regular PPV capsids. A high degree of purity of the recombinant capsids was obtained by ammonium sulphate precipitation of cell lysates. These virus-like particles were used as antigen in the immunization of two pigs. The pigs elicited an immune response which, when assayed by standard serological techniques, was identical to that of a commercial vaccine. The amount of recombinant antigen needed in a vaccine dose was only 3 micrograms in a primary dose and 1.5 micrograms in the booster.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1523879     DOI: 10.1016/0264-410x(92)90090-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  20 in total

1.  Parvovirus diagnostics and vaccine production in insect cells.

Authors:  J I Casal
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

2.  Influence of minor displacements in loops of the porcine parvovirus VP2 capsid on virus-like particles assembly and the induction of antibody responses.

Authors:  Qunxing Pan; Kongwang He; Yongshan Wang; Xiaoli Wang; Wei Ouyang
Journal:  Virus Genes       Date:  2013-02-21       Impact factor: 2.332

3.  First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs.

Authors:  J P Langeveld; J I Casal; A D Osterhaus; E Cortés; R de Swart; C Vela; K Dalsgaard; W C Puijk; W M Schaaper; R H Meloen
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

4.  Intranasal delivery of recombinant parvovirus-like particles elicits cytotoxic T-cell and neutralizing antibody responses.

Authors:  C Sedlik; A Dridi; E Deriaud; M F Saron; P Rueda; J Sarraseca; J I Casal; C Leclerc
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

5.  Strong buffering capacity of insect cells. Implications for the baculovirus expression system.

Authors:  M Medina; A López-Rivas; D Zuidema; G J Belsham; E Domingo; J M Vlak
Journal:  Cytotechnology       Date:  1995-02       Impact factor: 2.058

6.  Molecular detection of porcine parvovirus 1-associated reproductive failure in southern India.

Authors:  S Parthiban; R K V Sowndhraya; P Raja; M Parthiban; A Ramesh; G Dhinakar Raj; K Senthilkumar; D Balasubramanyam; S Hemalatha; R Bharathi; Chintu Ravishankar; S Thahira Parveen
Journal:  Trop Anim Health Prod       Date:  2022-06-02       Impact factor: 1.893

7.  Expression of porcine parvovirus VP2 gene requires codon optimized E. coli cells.

Authors:  Ting Qi; Shangjin Cui
Journal:  Virus Genes       Date:  2009-10       Impact factor: 2.332

8.  Vaccine efficacy against malaria by the combination of porcine parvovirus-like particles and vaccinia virus vectors expressing CS of Plasmodium.

Authors:  Dolores Rodríguez; Gloria González-Aseguinolaza; Juan R Rodríguez; Aneesh Vijayan; Magdalena Gherardi; Paloma Rueda; J Ignacio Casal; Mariano Esteban
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

9.  Production and purification of VP2 protein of porcine parvovirus expressed in an insect-baculovirus cell system.

Authors:  Hongchao Zhou; Guizhe Yao; Shangjin Cui
Journal:  Virol J       Date:  2010-12-10       Impact factor: 4.099

10.  A novel recombinant pseudorabies virus expressing parvovirus VP2 gene: Immunogenicity and protective efficacy in swine.

Authors:  Yang Chen; Wanzhu Guo; Zhiwen Xu; Qigui Yan; Yan Luo; Qian Shi; Dishi Chen; Ling Zhu; Xiaoyu Wang
Journal:  Virol J       Date:  2011-06-16       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.